Benralizumab (eosinophilic granulomatosis with polyangiitis) – 2nd Addendum to Project A24-113

Report documents

1. Addendum

   Benralizumab (eosinophilic granulomatosis with polyangiitis) – Addendum to Project A24-113

   published on

   15.05.2025

   Document type

   PDF-Dokument, 287 kB, DE, PDF

   DOI-Link

   https://doi.org/10.60584/G25-15

   Download file : Addendum (PDF-Dokument, 287 kB, DE, PDF)

Additional information

Project details

Project no.

G25-15

Commission

Commission awarded on 08.04.2025 by the Federal Joint Committee (GBA).

Report type

Addendum

Status

Commission completed

Department/Division

Health Economics

Topic

Immune system and infections

Note

If, in the course of the discussions on a commission of the GBA, a need for further revision arises, IQWiG submits an addendum. The GBA decides on the number of patients in the SHI target population.

DOI

https://doi.org/10.60584/G25-15

Connected Projects

1. Dossier assessment

   Benralizumab (eosinophilic granulomatosis with polyangiitis) – Benefit assessment according to §35a Social Code Book V

   Project no.

   A24-113

   Last updated

   04.03.2025

   Status: Commission completed